vedolizumab
vedolizumab is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand names including ENTYVIO Pen, ENTYVIO, Entyvio. Available dosage forms: injection, solution, injection, powder, lyophilized, for solution.
Drug details
- Generic Name
- vedolizumab
- Brand Names
- ENTYVIO Pen, ENTYVIO, Entyvio
- Application Number
- BLA761133
- Sponsor
- Takeda Pharmaceuticals America, Inc.
- NDC Codes
- 3
- Dosage Forms
- INJECTION, SOLUTION, INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- SUBCUTANEOUS, INTRAVENOUS
- Active Ingredients
- VEDOLIZUMAB
Indications and Usage
1 INDICATIONS AND USAGE ENTYVIO is indicated in adults for the treatment of: moderately to severely active ulcerative colitis (UC). moderately to severely active Crohn's disease (CD). ENTYVIO is an integrin receptor antagonist indicated in adults for the treatment of: moderately to severely active ulcerative colitis (UC). ( 1 ) moderately to severely active Crohn's disease (CD). ( 1 )